Commentary & Deal Flow

Roquette Frères SA, a family-owned global leader in plant-based ingredients and pharmaceutical solutions, (ticker: "ROQFRE", country: FR) rated BBB (negative outlook) by S&P, has mandated Crédit Agricole CIB, Goldman Sachs Bank Europe SE, Natixis and Société Générale as Global Coordinators along with BNP Paribas, CIC CIB, and J.P. Morgan as Active Bookrunners, to arrange a series of fixed income investor meetings, on 13-Apr-26. A presentation and voiceover are also available.

A new €500m expected Reg S Bearer PNC6 hybrid transaction with an expected issue rating of BB+ by S&P, may follow subject to market conditions.

Manufacturer target market (MiFID II/UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs / UK PRIIPs key information document (KID) has been prepared as not available to retail investors in the EEA or the UK. Relevant stabilisation regulation including FCA/ICMA will apply.

This communication is an advertisement. The final prospectus, when published, will be available on the website of the French Autorité des marchés financiers at www.amf-france.org and on the Issuer’s website (https://www.roquette.com/).